The European Journal of Musculoskeletal Diseases is currently published by Lab Publishers. The journal was acquired from Biolife Sas in 2026. The transition has been carried out with full continuity of the journal’s editorial scope, policies, and peer-review process. The Editor-in-Chief has been updated as part of the transition, while maintaining the journal’s scientific standards and mission.
Journal
- EJMD VOL. 15 N. 2, May-Aug, 2026
- EJMD 2026 Vol. 15 issue n. 1
- EJMD 2025 Vol. 14 issue n. 3
- EJMD 2025 Vol. 14 issue n. 2
- EJMD 2025 Vol. 14 issue n. 1
- EJMD 2024 Vol. 13 issue n. 3
- EJMD 2024 Vol. 13 issue n. 2
- EJMD 2024 Vol. 13 issue n. 1
- EJMD 2023 Vol. 12 issue n. 3
- EJMD 2023 Vol. 12 issue n. 2
- EJMD 2023 Vol. 12 issue n. 1
- EJMD 2022 Vol. 11 issue n. 3
- EJMD 2022 Vol. 11 issue n. 2
- EJMD 2022 Vol. 11 issue n. 1
- EJMD 2021 Vol. 10 issue n. 3
- EJMD 2021 Vol. 10 issue n. 2
- EJMD 2021 Vol. 10 issue n. 1
Keywords
acute kidney injury
apoptosis
bone
cancer
cell proliferation
children
colorectal cancer
dental implants
endometriosis
fixture
gastric cancer
hyaluronic acid
IL-6
implant
inflammation
inflammatory factors
invasion
lung cancer
malocclusion
mast cell
mast cells
NF-κB
obesity
oral health
Oral surgery
orthodontics
osseointegration
ovarian cancer
oxidative stress
oxygen-ozone
ozone
pain
periodontitis
preeclampsia
probiotics
prognosis
proliferation
regeneration
rehabilitation
resorption
SARS-CoV-2
sepsis
surgery
TGF-β1
tooth
CALL FOR PAPERS
Please submit your papers to:
ejmd@lab-publishers.com
Contacts
Submit your article to:
e-mail: ejmd@lab-publishers.com.
Editorial correspondence:
Dr Matteo Bonetti
e-mail: ejmd@lab-publishers.com
Commercial correspondence
including advertising, requests for back numbers and reprints should be sent electronically to
e-mail: info@lab-publishers.com.